关于先锋

Company Profile

Pioneer Information

Notice Announcement

Industry News

Environmental information disclosure

Sichuan Province is enforcing the drug

Release time:

2023-07-24

Common name Actual Specifications Conversion ratio
Anetellithin Tablets 25mg 12
Anetellithin Tablets 25mg 24
Guipi Capsule 0.3g 24
Guipi Capsule 0.3g 36
Cefoxitin Sodium for Injection 0.5g 1
Cefoxitin Sodium for Injection 1.0g 1
Cefoxitin Sodium for Injection 3.0g 1
Sodium fructose diphosphate for injection 5g (as anhydrous) 1
Diammonium glycyrrhizinate enteric-coated tablets 50mg 12
Diammonium glycyrrhizinate enteric-coated tablets 50mg 24
Fenofibrate Capsules 0.2g 20
Sodium ferulate for injection 0.3g 1
Sodium ferulate for injection 0.2g 1
Sodium ferulate for injection 0.1g 1
Clindamycin hydrochloride for injection 0.15g 1
Ambroxol Hydrochloride Capsules 60mg 12
Ambroxol Hydrochloride Capsules 60mg 24
Sodium creatine phosphate for injection 1.0g 1
Sodium creatine phosphate for injection 0.5g 1
Ambroxol Hydrochloride Capsules 30mg 36
Ambroxol Hydrochloride Capsules 30mg 12
Ambroxol Hydrochloride Capsules 30mg 24
Azithromycin for Injection 0.5g 10
Back →

Related news

2023-03-08

Warmly welcome the entrepreneurs from the 39th class committee of Cheung Kong Graduate School of Business to visit Pioneer Pharmaceutical

Warmly welcome the entrepreneurs from the 39th class committee of Cheung Kong Graduate School of Business to visit Pioneer Pharmaceutical

2023-02-27

Warmly congratulate Pioneer Pharmaceutical Clindamycin Phosphate Injection on obtaining the new approval document, new standard and new Ruijia for generic drug registration!

Warmly congratulate Pioneer Pharmaceutical Clindamycin Phosphate Injection on obtaining the new approval document, new standard and new Ruijia for generic drug registration!

2023-02-25

Warmly congratulate Anhui Pioneer Pharmaceutical Fenofibrate Capsules for being the first to pass the consistency evaluation of generic drugs

Warmly congratulate Anhui Pioneer Pharmaceutical Fenofibrate Capsules for being the first to pass the consistency evaluation of generic drugs